Latest news with #Teladoc
CNBC
2 days ago
- Business
- CNBC
14. Transcarent
Founder: Glen Tullman (CEO)Launched: 2020Headquarters: Denver, ColoradoFunding: $940 millionValuation: $3 billionKey Technologies: Artificial intelligence, generative AIIndustry: Health carePrevious appearances on Disruptor 50 list: 1 (No. 17 in 2024) Over a third of insured adults say it's difficult to understand what their health insurance covers, according to research from health policy organization KFF. The confusion that comes with navigating insurance can result in more costly medical bills. Digital health startup Transcarent wants to tackle this challenge and help Americans receive affordable, high-quality care. Designed for self-insured employers and their workforces, Transcarent provides employees with personalized care, medication savings and information regarding their benefits. Members are guided based on their individual medical history and insurance plan, and their top spending categories, whether it is cancer care, muscle and joint health, mental health or weight management. Transcarent also provides pharmacy care and claims that it has saved clients 40% on pharmacy costs. The information that is analyzed for each member is designed to suggest next clinical steps and connect them with virtual and in-person medical professionals best suited to treat their specific needs. It is also creating more narrow one-stop shop solutions based on critical health needs. Transcarent partnered with Evernorth Health Services' new Oncology Benefit Services program in October, combining cancer services, medical benefits and personalized patient support in one digital platform. The biggest deal for Transcarent closed in April, when it officially acquired Accolade, a health-care delivery, navigation and advocacy service which had gone public in 2020, for $621 million. Now working as a combined organization, Transcarent and Accolade are serving more than 20 million members, along with over 1,700 employer and health plan clients. "Transcarent and Accolade coming together is an important step to make it easier for everyone to access the high-quality, affordable health and care they deserve," said Transcarent CEO Glen Tullman in a statement. Before Transcarent, Tullman was the CEO of remote health management company Livongo until it was acquired by Teladoc in 2020. At that time, the merger led the companies to a joint enterprise value of $37 billion. Now, Teladoc's market cap is just under $2 deal is a poster child for the the growing pains that the digital health sector has run into after a rapid rise during the Covid era. Accolade was one of the many digital health companies that went private due to the industry slowdown in 2024. Despite this post-pandemic shift, Transcarent announced a $126 million Series D investment last year led by General Catalyst and 7wireVentures, where Tullman is co-founder and serves as a managing partner. In an interview with health and medicine news site STAT, Tullman said that Transcarent plans to use its latest funding to further expand its application's AI and pursue additional acquisitions.
Yahoo
2 days ago
- Business
- Yahoo
Teladoc (TDOC) Outperforms Broader Market: What You Need to Know
The latest trading session saw Teladoc (TDOC) ending at $7.40, denoting a +1.79% adjustment from its last day's close. The stock's change was more than the S&P 500's daily gain of 0.09%. The telehealth services provider's stock has climbed by 2.25% in the past month, exceeding the Medical sector's gain of 2.17% and lagging the S&P 500's gain of 7.21%. The upcoming earnings release of Teladoc will be of great interest to investors. The company is predicted to post an EPS of -$0.23, indicating a 17.86% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $621.92 million, indicating a 3.19% decline compared to the corresponding quarter of the prior year. For the full year, the Zacks Consensus Estimates project earnings of -$1.17 per share and a revenue of $2.51 billion, demonstrating changes of +80.07% and -2.15%, respectively, from the preceding year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Teladoc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an 8.56% increase. Currently, Teladoc is carrying a Zacks Rank of #3 (Hold). The Medical Services industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 68, which puts it in the top 28% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
6 days ago
- Business
- Yahoo
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as the Bureau of Labor Statistics report revealed a resilient labor market with non-farm payrolls rising by 139,000 in May 2025, significantly above the consensus forecast of 125,000. Notably, a stable labor market often supports consumer spending, which is a key driver of economic growth, which means the report could help ease some of the recession fears that gripped markets. The data also supports the soft landing narrative, where the Fed can manage inflation toward its 2% target without significant damage to the economy. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Gaming Solutions company DraftKings (NASDAQ:DKNG) jumped 6.2%. Is now the time to buy DraftKings? Access our full analysis report here, it's free. Online Marketplace company Teladoc (NYSE:TDOC) jumped 5.7%. Is now the time to buy Teladoc? Access our full analysis report here, it's free. Gaming Solutions company Rush Street Interactive (NYSE:RSI) jumped 5.9%. Is now the time to buy Rush Street Interactive? Access our full analysis report here, it's free. Therapeutics company Moderna (NASDAQ:MRNA) jumped 5.1%. Is now the time to buy Moderna? Access our full analysis report here, it's free. Ground Transportation company Avis Budget Group (NASDAQ:CAR) jumped 5.8%. Is now the time to buy Avis Budget Group? Access our full analysis report here, it's free. DraftKings's shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 4 days ago when the stock dropped 7% on the news that the state of Illinois announced new legislation that introduces additional fees for online sports betting operators. The new fee structure is expected to significantly increase the tax rate for major players like DraftKings in Illinois, potentially reducing their profitability. DraftKings is down 1.4% since the beginning of the year, and at $35.79 per share, it is trading 33.1% below its 52-week high of $53.49 from February 2025. Investors who bought $1,000 worth of DraftKings's shares 5 years ago would now be looking at an investment worth $941.84. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as the Bureau of Labor Statistics report revealed a resilient labor market with non-farm payrolls rising by 139,000 in May 2025, significantly above the consensus forecast of 125,000. Notably, a stable labor market often supports consumer spending, which is a key driver of economic growth, which means the report could help ease some of the recession fears that gripped markets. The data also supports the soft landing narrative, where the Fed can manage inflation toward its 2% target without significant damage to the economy. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Gaming Solutions company DraftKings (NASDAQ:DKNG) jumped 6.2%. Is now the time to buy DraftKings? Access our full analysis report here, it's free. Online Marketplace company Teladoc (NYSE:TDOC) jumped 5.7%. Is now the time to buy Teladoc? Access our full analysis report here, it's free. Gaming Solutions company Rush Street Interactive (NYSE:RSI) jumped 5.9%. Is now the time to buy Rush Street Interactive? Access our full analysis report here, it's free. Therapeutics company Moderna (NASDAQ:MRNA) jumped 5.1%. Is now the time to buy Moderna? Access our full analysis report here, it's free. Ground Transportation company Avis Budget Group (NASDAQ:CAR) jumped 5.8%. Is now the time to buy Avis Budget Group? Access our full analysis report here, it's free. DraftKings's shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 4 days ago when the stock dropped 7% on the news that the state of Illinois announced new legislation that introduces additional fees for online sports betting operators. The new fee structure is expected to significantly increase the tax rate for major players like DraftKings in Illinois, potentially reducing their profitability. DraftKings is down 1.4% since the beginning of the year, and at $35.79 per share, it is trading 33.1% below its 52-week high of $53.49 from February 2025. Investors who bought $1,000 worth of DraftKings's shares 5 years ago would now be looking at an investment worth $941.84. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-05-2025
- Business
- Yahoo
Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report?
A month has gone by since the last earnings report for Teladoc (TDOC). Shares have lost about 0.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Teladoc due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. It turns out, fresh estimates have trended downward during the past month. The consensus estimate has shifted -13.87% due to these changes. At this time, Teladoc has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Following the exact same course, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy. Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Teladoc has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Teladoc belongs to the Zacks Medical Services industry. Another stock from the same industry, Avantor, Inc. (AVTR), has gained 0.6% over the past month. More than a month has passed since the company reported results for the quarter ended March 2025. Avantor reported revenues of $1.58 billion in the last reported quarter, representing a year-over-year change of -5.9%. EPS of $0.23 for the same period compares with $0.22 a year ago. Avantor is expected to post earnings of $0.25 per share for the current quarter, representing no change from the year-ago quarter. Over the last 30 days, the Zacks Consensus Estimate remained unchanged. The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for Avantor. Also, the stock has a VGM Score of C. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report Avantor, Inc. (AVTR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
